Last reviewed · How we verify
Contrast enhanced Ultrasound
Contrast enhanced Ultrasound is a Small molecule drug developed by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. It is currently FDA-approved. Also known as: CEUS, Optison.
At a glance
| Generic name | Contrast enhanced Ultrasound |
|---|---|
| Also known as | CEUS, Optison |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder (NA)
- Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules (NA)
- CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma
- Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy (EARLY_PHASE1)
- Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania (NA)
- Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging (PHASE4)
- Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients (NA)
- Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Contrast enhanced Ultrasound CI brief — competitive landscape report
- Contrast enhanced Ultrasound updates RSS · CI watch RSS
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University portfolio CI
Frequently asked questions about Contrast enhanced Ultrasound
What is Contrast enhanced Ultrasound?
Contrast enhanced Ultrasound is a Small molecule drug developed by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University.
Who makes Contrast enhanced Ultrasound?
Contrast enhanced Ultrasound is developed and marketed by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (see full Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University pipeline at /company/sun-yat-sen-memorial-hospital-of-sun-yat-sen-university).
Is Contrast enhanced Ultrasound also known as anything else?
Contrast enhanced Ultrasound is also known as CEUS, Optison.
What development phase is Contrast enhanced Ultrasound in?
Contrast enhanced Ultrasound is FDA-approved (marketed).
Related
- Manufacturer: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — full pipeline
- Also known as: CEUS, Optison
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing